Press Release

Atopic Dermatitis Market 2019 Global Industry Growth Analysis, Segmentation, Size, Share, Trend, Future Demand and Leading Players Updates by Forecast to 2026

Atopic Dermatitis Market 2019 Global Industry Share, Size, Future Demand, Global Research, Top Leading Players, Emerging Trends, Region by Forecast to 2026

The increasing advancement in Atopic Dermatitis Market and its rising prevalence is boosting the global atopic dermatitis treatment market, predicts Fortune Business Insights, in their new report. The report is titled, “Atopic Dermatitis Treatment Market Size, Share and Global Trend by Drug Class (Corticosteroids, Anti-histamines, Calcineurin inhibitors, Interleukin inhibitors, Topical phosphodiesterase-4, Antibiotics, Others), By Route of Administration (Oral, Topical, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), And Geography Forecast till 2026.”

global atopic dermatitis treatment market is

  • Novartis,
  • Calcineurin inhibitors
  • Allergan
  • Corticosteroids
  • Astellas Pharma US
  • Bayer
  • Antihistamines
  • Regeneron Pharmaceuticals
  • Pfizer
  • Emollients
  • Meda

Browse Complete Report:

According to the report, the global market for atopic dermatitis treatment is anticipated to be dominated by the Corticosteroids sub-segment, on the basis of segmentation by drug class. This is likely to remain the same in the coming years because of the fact that corticosteroids are the first line of treatment for the disease.

Rising Incidents of Skin Allergies in Infants, to Propel Demand

The Asthma and Allergy Foundation of America stated in 2016, about an approximate of 7.3% of people suffered from atopic dermatitis in the U.S. Additionally, the British Association of dermatologists also state one in every five children in the United Kingdom is affected by skin problems such as eczema at any stage of his life. The National Institute of Health and Care Excellence estimates one in every 12 adults in the United States is affected by atopic dermatitis. The aforementioned statistics all indicate the problem of skin problems to be a major driver for the growth of the global atopic dermatitis treatment.

Fortune Business Insights predicts various factors responsible for the growth of the global atopic dermatitis treatment market. These factors include the rising number of cases of allergy among infants, increasing healthcare facilities in developed nations and rise in disposable incomes. The increasing prevalence of food allergies is also expected to help th market generate major revenues in the coming years.

However, certain factors such as the non-curable nature of the disease may hinder the growth of the market in the coming years. Furthermore, the introduction of generic treatment methods, coupled with strict regulations imposed by the government with regard to medication used for treating atopic dermatitis may affect the market in negative light, during the forecast period.

Get Sample PDF:

Improving Healthcare Facilities to Help Asia Pacific Register Faster Growth

Fortune Business Insights foresees the global atopic dermatitis treatment market to be dominated by North America, shortly followed by Europe. This is owing to the easy healthcare access and availability of better facilities in the region. This, coupled with, the rising incidences of skin problems in the region is anticipated to boost the market in the region.

On the other side, the market for atopic dermatitis in Asia Pacific is anticipated to witness progressive growth on account of the rising awareness about skin problems occurring in infants and small children and improving healthcare infrastructure and facilities scenario in developing economies of India, and China.

Key merger and acquisition strategies adopted by major market players is estimated to help the market grow remarkably in the coming years. Some of the companies operating in the

Speak to Analyst:

View Related Reports:

Hereditary Angioedema Treatment Market Size to Reach USD 6533.3 Million by 2025 | Top Players Covered as BIOCRYST PHARMACEUTICALS, Ionis Pharmaceuticals, Attune Pharmaceuticals & More

MRI Market Size, Global Industry Share, SWOT Analysis & Forecast Report 2018-2025

Global Medical Robotic Systems Market Size, Share, Top 10 Players Profile, Industry Analysis & Forecast 2019 to 2026


Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *